cross-posted from : https://lemmy.zip/post/73756861

non paywall

Debbie Doppelt, a 60-year-old jeweler with an unusual form of lung cancer that afflicts mostly nonsmokers like her. The Food and Drug Administration hadn't yet approved sunvozertinib, a drug developed in China that targets the mutation driving Doppelt's tumors.

Sunvozertinib, made by Shanghai-based Dizal Pharmaceutical, isn't the only treatment drawing patients to China. Americans, Europeans and others are trekking there to enter clinical trials for CAR-T therapy, an area in which China has become a world leader.

you are viewing a single comment's thread
view the rest of the comments
[–] 2 points 2 weeks ago

Actionable summary of this story:

Guys mom has lung cancer and treatments weren't working. By chance they discovered an approved treatment in another country that is working. So he built this tool to connect patients with treatments and trials across international borders. https://data-vault.health

  • source